Loading stock data…
$10.46-0.15 (-1.45%)
Lumexa Imaging Holdings, Inc.
Lumexa Imaging Holdings, Inc. in the Healthcare sector is trading at $10.46 with a market capitalization of $1.1B. Wall Street consensus targets $17.67 (9 analysts), implying a +69.0% move over the next 12 months. The stock is currently 46% below its 52-week high of $19.45, remaining 8.7% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $264.16M↑ | $252.54M↓ | $267.73M↑ | $258.94M↑ | $251.40M |
| Gross Profit | $38.88M↑ | $34.78M↓ | $42.12M↑ | $39.71M↑ | $39.14M |
| Operating Income | $4.40M↓ | $4.53M↑ | -$7.47M↓ | $12.97M↑ | $11.17M |
| Net Income | $2.75M↑ | $1.72M↑ | -$28.69M↓ | -$3.50M↑ | -$7.23M |
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomog...